First Bard Vein Filter Bellwether Heads to Jury
By Cara Salvatore Law360
Law360, Phoenix (March 29, 2018, 11:30 PM EDT) – a Phoenix federal jury began deliberations Thursdays in the first bellwether trial in multidistrict litigation over claims that device maker Bard’s clot-stopping vein implants splinted and migrated towards patients’ hearts, after Bard closed its case by arguing evidence concerning predecessor implants and FDA warnings were red herrings . . .
Latest Posts
by Gay MennutiBeus Gilbert McGroder PLLC
It is with tremendous pride and pleasure that we announce the firm's name has changed to BEUS GILBERT MCGRODER PLLC with the addition of Patrick J....
by Gay MennutiValley Law Firm Adds Respected Surname to Title
Greg Barr at gbarr@bizjournals.comThe orders are in for new business cards at one of the Valley’s best-known firms, now that Beus Gilbert LLC has...
by Gay MennutiBeus Gilbert law firm adds high-profile attorneys Patrick McGroder and Jay Heiler
Russ Wiles, Arizona Republic Oct. 15 2018Phoenix law firm Beus Gilbert PLLC has added two prominent Valley attorneys, including a plaintiffs...